• Profile
Close

Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study

Diabetes Research and Clinical Practice Jul 27, 2021

Nicolucci A, Chen H, Cid-Ruzafa J, et al. - Researchers conducted the study for examining factors correlated with health-related quality of life (HRQoL) in patients with type 2 diabetes mellitus (T2D) at the initiation of second-line glucose-lowering therapy. DISCOVER is a 3-year, prospective observational study of patients with T2D starting second-line glucose-lowering therapy, carried out in 38 countries. The physical and mental component summary scores of the 36-Item Short Form Health Survey version 2 (SF-36v2) in 31 countries (n = 8,309) and the Hypoglycaemia Fear Survey-II (HFS-II) in 23 countries (n = 6,516) were used to assess HRQoL at baseline. Using multivariable hierarchical regression models, factors associated with differences in HRQoL were assessed. Female gender, a history of macrovascular complications, and first-line treatment with oral combinations (vs metformin monotherapy) were all associated with significantly lower SF-36v2 scores. Several patient-, disease-, and treatment-related characteristics were found to be related to HRQoL, indicating that a multifactorial approach is required to maintain HRQoL in T2D patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay